Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

NCT00014456 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Breast Cancer
Carcinoma of Unknown Primary
Esophageal Cancer
Gastric Cancer
Head and Neck Cancer
Lung Cancer
Melanoma (Skin)
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Sarcoma

Interventions

BIOLOGICAL: filgrastim
DRUG: docetaxel
DRUG: gemcitabine hydrochloride

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]